Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank93
3Y CAGR+20.1%
5Y CAGR+36.8%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
+20.1%/yr
vs +17.8%/yr prior
5Y CAGR
+36.8%/yr
Recent deceleration
Acceleration
+2.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20252.06+90.6%
20241.08-21.8%
20231.38+16.2%
20221.19+59.8%
20210.74+73.1%
20200.43-63.7%
20191.18+91.9%
20180.62-71.1%
20172.13+335.3%
20160.49-